Kunzah Jamal

Preclinical Characterization of AZD5305, A Next-Generation, Highly Selective PARP1 Inhibitor and Trapper

Giuditta Illuzzi, Anna D. Staniszewska, Sonja J. Gill et al. · Clinical Cancer Research · 2022 · 171 citations · Full text

Medicine, Oncology, Pharmacology +13

Preclinical Characterization of AZD9574, a Blood–Brain Barrier Penetrant Inhibitor of PARP1

Anna D. Staniszewska, Domenic Pilger, Sonja J. Gill et al. · Clinical Cancer Research · 2023 · 58 citations

Medicine, Oncology, Pharmacology +14

Drug–gene Interaction Screens Coupled to Tumor Data Analyses Identify the Most Clinically Relevant Cancer Vulnerabilities Driving Sensitivity to PARP Inhibition

Kunzah Jamal, Alessandro Galbiati, Joshua Armenia et al. · Cancer Research Communications · 2022 · 26 citations · Full text

Life Sciences, Genetics, Oncology +13

Abstract 2609: AZD9574 is a novel, brain penetrant PARP-1 selective inhibitor with activity in an orthotopic, intracranial xenograft model with aberrant DNA repair

Kunzah Jamal, Anna D. Staniszewska, Jacob Gordon et al. · Cancer Research · 2022 · 20 citations

Life Sciences, Molecular Biology, Oncology +17